TLR4 and acute myeloid leukemia: Taken together these studies suggest that TLR4 expression by AML cells is associated with an adverse prognosis (i.e., a part of a high-risk leukemic cell phenotype), and TLR4 inhibition can have a chemosensitizing and/or direct antileukemic effect.